rs2306914

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The NM_182961.4(SYNE1):​c.16277C>T​(p.Thr5426Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0331 in 1,614,120 control chromosomes in the GnomAD database, including 1,416 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.028 ( 124 hom., cov: 33)
Exomes 𝑓: 0.034 ( 1292 hom. )

Consequence

SYNE1
NM_182961.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.908
Variant links:
Genes affected
SYNE1 (HGNC:17089): (spectrin repeat containing nuclear envelope protein 1) This gene encodes a spectrin repeat containing protein expressed in skeletal and smooth muscle, and peripheral blood lymphocytes, that localizes to the nuclear membrane. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia 8, also referred to as autosomal recessive cerebellar ataxia type 1 or recessive ataxia of Beauce. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SYNE1. . Gene score misZ -0.29069 (greater than the threshold 3.09). Trascript score misZ 3.2909 (greater than threshold 3.09). GenCC has associacion of gene with autosomal recessive ataxia, Beauce type, autosomal recessive myogenic arthrogryposis multiplex congenita, Emery-Dreifuss muscular dystrophy 4, autosomal dominant, arthrogryposis multiplex congenita 3, myogenic type, autosomal dominant Emery-Dreifuss muscular dystrophy.
BP4
Computational evidence support a benign effect (MetaRNN=0.0011658967).
BP6
Variant 6-152318975-G-A is Benign according to our data. Variant chr6-152318975-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 130410.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-152318975-G-A is described in Lovd as [Benign]. Variant chr6-152318975-G-A is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.142 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SYNE1NM_182961.4 linkuse as main transcriptc.16277C>T p.Thr5426Met missense_variant 85/146 ENST00000367255.10 NP_892006.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SYNE1ENST00000367255.10 linkuse as main transcriptc.16277C>T p.Thr5426Met missense_variant 85/1461 NM_182961.4 ENSP00000356224 P1Q8NF91-1

Frequencies

GnomAD3 genomes
AF:
0.0282
AC:
4291
AN:
152164
Hom.:
124
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00649
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0291
Gnomad ASJ
AF:
0.0182
Gnomad EAS
AF:
0.151
Gnomad SAS
AF:
0.0325
Gnomad FIN
AF:
0.0375
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0309
Gnomad OTH
AF:
0.0282
GnomAD3 exomes
AF:
0.0410
AC:
10296
AN:
251368
Hom.:
416
AF XY:
0.0396
AC XY:
5379
AN XY:
135870
show subpopulations
Gnomad AFR exome
AF:
0.00535
Gnomad AMR exome
AF:
0.0493
Gnomad ASJ exome
AF:
0.0156
Gnomad EAS exome
AF:
0.165
Gnomad SAS exome
AF:
0.0281
Gnomad FIN exome
AF:
0.0401
Gnomad NFE exome
AF:
0.0295
Gnomad OTH exome
AF:
0.0362
GnomAD4 exome
AF:
0.0336
AC:
49184
AN:
1461838
Hom.:
1292
Cov.:
32
AF XY:
0.0332
AC XY:
24113
AN XY:
727210
show subpopulations
Gnomad4 AFR exome
AF:
0.00496
Gnomad4 AMR exome
AF:
0.0489
Gnomad4 ASJ exome
AF:
0.0150
Gnomad4 EAS exome
AF:
0.155
Gnomad4 SAS exome
AF:
0.0254
Gnomad4 FIN exome
AF:
0.0406
Gnomad4 NFE exome
AF:
0.0303
Gnomad4 OTH exome
AF:
0.0341
GnomAD4 genome
AF:
0.0282
AC:
4287
AN:
152282
Hom.:
124
Cov.:
33
AF XY:
0.0290
AC XY:
2163
AN XY:
74466
show subpopulations
Gnomad4 AFR
AF:
0.00648
Gnomad4 AMR
AF:
0.0291
Gnomad4 ASJ
AF:
0.0182
Gnomad4 EAS
AF:
0.151
Gnomad4 SAS
AF:
0.0323
Gnomad4 FIN
AF:
0.0375
Gnomad4 NFE
AF:
0.0309
Gnomad4 OTH
AF:
0.0284
Alfa
AF:
0.0293
Hom.:
174
Bravo
AF:
0.0282
TwinsUK
AF:
0.0297
AC:
110
ALSPAC
AF:
0.0317
AC:
122
ESP6500AA
AF:
0.00590
AC:
26
ESP6500EA
AF:
0.0272
AC:
234
ExAC
AF:
0.0393
AC:
4768
Asia WGS
AF:
0.0770
AC:
267
AN:
3478
EpiCase
AF:
0.0281
EpiControl
AF:
0.0261

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingGeneDxJan 28, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
not provided Benign:2
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Autosomal recessive ataxia, Beauce type Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.75
T
BayesDel_noAF
Benign
-0.71
CADD
Benign
11
DANN
Benign
0.61
DEOGEN2
Benign
0.070
T;.;T;.
Eigen
Benign
-0.79
Eigen_PC
Benign
-0.59
FATHMM_MKL
Benign
0.081
N
LIST_S2
Benign
0.71
T;T;T;T
MetaRNN
Benign
0.0012
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-1.5
N;.;.;.
MutationTaster
Benign
1.0
P;P;P;P;P
PrimateAI
Benign
0.24
T
PROVEAN
Benign
0.28
N;.;N;.
REVEL
Benign
0.053
Sift
Benign
0.19
T;.;T;.
Sift4G
Benign
0.57
T;T;T;T
Polyphen
0.0010
B;.;.;.
Vest4
0.062
MPC
0.14
ClinPred
0.0087
T
GERP RS
0.29
Varity_R
0.023
gMVP
0.082

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2306914; hg19: chr6-152640110; COSMIC: COSV54935615; COSMIC: COSV54935615; API